To evaluate the effect of comparison mammograms on accuracy, sensitivity, specifi city, positive predictive value (PPV 1 ), and cancer detection rate (CDR) of screening mammography to determine the role played by identifi cation of change on comparison mammograms .
BREAST IMAGING: Change from Comparison Mammograms
Yankaskas et al the cost-effectiveness of obtaining comparison mammograms showed that the process of retrieving previous mammograms to compare with current mammograms has a high cost and yields small benefi ts ( 3, 8 ) ; meanwhile, it does not provide any clinical benefi t to the majority of the patients. The objective of this study was to evaluate the effect of comparison mammograms on the accuracy, sensitivity, specifi city, positive predictive value (PPV 1 ), and cancer detection rate of screening mammography to determine the role played by identifi cation of change on mammograms.
Materials and Methods
This study was reviewed and approved by the biomedical institutional review board at the University of North Carolina at Chapel Hill and was compliant with the Health Insurance Portability and Accountability Act. The study received a waiver of patient informed consent.
Study Population
We identifi ed 1 342 662 screening mammograms obtained in 504 589 women aged 40 or more years who were seen at facilities participating in the Carolina Mammography Registry between 1994 was no difference in the number of truepositive fi ndings ( 2 ) . When comparison mammograms were used, cancers were detected at an earlier stage. In another study , researchers evaluated abnormal screening mammograms obtained as part of a screening program at one institution. They compared initial screening mammograms for which no comparison mammograms were available with mammograms obtained at subsequent screening for which comparison mammograms were available. They found the abnormal rate (recall rate) was two times higher when no comparison mammograms were available, but they did not control for age. Cancers detected with comparison mammograms available had more favorable characteristics ( 3 ) . There are four other studies reported in the literature in which researchers used test sets read by multiple radiologists with varying methods. All studies report that the use of comparison mammograms improves specifi city, with fewer false-positive results ( 4-7 ). In none of these studies did researchers fi nd any difference in cancer detection rates. In one report, there was no difference in sensitivity ( 7 ) .
Radiologists feel more confi dent reporting an abnormality on a current mammogram when previous images are available for comparison ( 8 ) . However, two studies in which researchers evaluated T he medical community generally accepts the notion that the availability of prior mammograms improves interpretation of screening mammograms and clinical outcome. The American College of Radiology states in their practice guidelines, "Comparison with available prior breast imaging studies is an important part of mammography," and "If previous breast imaging studies are needed for assessing mammographic fi ndings, an attempt should be made to obtain them" ( 1 ). This recommendation is based on the fi ndings of Burnside et al ( 2 ) , who used consecutive screening mammograms obtained at fi xed sites within one institution. They reported that false-positive results were signifi cantly reduced with use of comparison mammograms; however, there
Implications for Patient Care
Cancers detected with or without n change from comparison mammograms are similar.
Careful review is indicated when n change is noted to reduce the false-positive rate but not the sensitivity.
The percentage of women in n whom biopsy is recommended in the presence of change on comparison mammograms is close to the percentage of women in whom biopsy is recommended in the presence of no change; however, a large percentage of women with no change undergo additional imaging and do not have cancer.
Advances in Knowledge
Use of comparison mammograms n at screening mammography results in lower recall rates (6.9% with comparison mammograms vs 14.9% without comparison mammograms) and higher specifi city (93.5% with comparison mammograms vs 85.7% without comparison mammograms).
When change from comparison n mammograms is noted at screening mammography, recall rate, sensitivity, and cancer detection rate are higher than when no change is noted; however, specifi city is lower, indicating a high false-positive rate.
On the majority of screening n mammograms on which change from comparison mammograms is not noted, recall rate, sensitivity, and cancer detection rate are low (2.0%, 43.5%, 0.8%, respectively, without comparison), while specifi city is high. 
Data Analysis
We will fi rst describe the characteristics of the women whose mammograms were included in the study, then we will describe the characteristics of the women whose mammograms were excluded. Sensitivity was defi ned as the proportion of patients in whom breast cancer was diagnosed who had positive to classify breast density and to assess the screening images ( 9 ) . Mammographic fi ndings were classifi ed as negative if the BI-RADS score was 1 (normal), 2 (benign), or 3 (probably benign), unless the latter classifi cation was associated with a recommendation for immediate work-up . Mammographic fi ndings were considered positive if the BI-RADS score was 3 with recommendation for immediate work-up, 4 (suspicious abnormality), 5 (highly suggestive of cancer), or 0 (needs additional work-up). Recommendation for biopsy was based on the fi nal assessment at the end of the imaging work-up. If the BI-RADS score was 4 or 5 or if biopsy or surgical consultation was recommended, recommendation for biopsy was coded yes ; otherwise, it was coded no . Cancer diagnosis was determined by linking to the North Carolina Central Cancer Registry to indentify cancers diagnosed within 12 months after screening mammography and to a pathology database from and 2008. Screening mammography was defi ned as a mammographic examination performed in an asymptomatic woman, as reported by the radiologist or technologist at the time of the visit. To reduce the possibility of having diagnostic mammograms included as screening mammograms, mammograms were excluded if there were not at least 9 months between a previous examination and the current examination. We excluded a total of 184 682 (13.8%) mammograms for the following reasons: A total of 12 333 (0.9%) mammograms were obtained in women who had a personal history of breast cancer. A total of 19 136 (1.4%) mammograms were obtained in women who had breast implants. For 161 148 (12.0%) mammograms, it was unknown if a comparison mammogram had been used. Of the excluded mammograms, 2492 (1.3%) were excluded for two or more reasons. The fi nal study population included 1 157 980 screening mammograms obtained in 435 183 women ( Fig 1 ) .
The Carolina Mammography Registry is a population-based study of screening in community practice. Data are prospectively collected from practices located in 39 counties in North Carolina. Patient demographics and imaging information, results, and recommendations are recorded for every screening examination in all women. Demographic and risk factor data are recorded directly from women's self-reports. Demographic data include date of birth, race or ethnicity, zip code, and education level. Risk factor data include personal and family history of breast cancer, previous mammography, breast symptoms, and history of breast procedures, including surgery. Women also report hormone use and menopausal status. The radiologist or technologist records specifi cs about the examinations, including the indication for the examination, what type of examination was performed, breast density as seen on the mammogram, mammographic fi ndings, and recommendation for follow-up. By defi nition, all screening examinations were bilateral (craniocaudal and mediolateral oblique). The coding system of the Breast Imaging Reporting and Data System (BI-RADS) of the American College of Radiology was used ( Table 1 ) .
Change versus no change.-There were 1 077 794 (93.1%) mammograms for which a comparison mammogram was available. Of these, 132 123 (12.3%) showed a change, while 940 056 (87.7%) showed no change. The mammograms that showed a change were obtained in women who were similar in age to those with no change. For other characteristics, the percentage with change compared to the percentage with no change was: (a) higher in mammograms obtained in white women than in those obtained in black women, (b) higher in women with no family history of breast cancer than in women who had a family history of breast cancer, (c) higher in women who used hormone therapy than in women who did not use hormone therapy, (d) higher in women with less-dense breasts than in women with extremely or heterogeneously dense breasts, and (e) higher in women with a history of breast biopsy or surgery ( Table 1 ) . Because of the large number of images, all comparisons were signifi cant ( P , .001).
Cancer Outcomes and Screening Performance
Cancer rate.-A total of 5738 cancers were diagnosed within 1 year of screening mammography in the study population. Of these, 5085 were diagnosed with the aid of a comparison mammogram, measures depend on whether there is change in the comparison image after adjusting for the same variables. Since the standard errors were calculated by using generalized estimating equations ( 11 ) to calculate statistical signifi cance, a z test was performed with the parameter estimates from the logistic regression models by using generalized estimating equations and the corresponding standard errors, which were adjusted for the nonnested structure of the data. A P value of less than .05 was considered to indicate a signifi cant difference. All statistical analysis was conducted by using SAS software (version 9.2; SAS Institute, Cary, NC).
Results

Descriptive Results
The excluded mammograms were obtained in women who were slightly younger (30% were obtained in women aged 40-49 years, 31% were obtained in women aged 50-59 years, 22% were obtained in women aged 60-69 years, and 17% were obtained in women aged Ն 70 years ), had a slightly different racial background (black, 19.9%; white, 75.4%; other, 4.7%); had a slightly higher family history of breast cancer (12.9%), reported less use of hormone therapy (12.8%), had a slightly different breast density distribution (extremely dense , 4.4%; heterogeneously dense, 31.6%; scattered fi brodensity, 29.8%; and entirely fat, 6.2%), and had a slightly lower history of breast surgery (20.8%) than did the overall study population.
For the descriptive data, all of the bivariate associations with whether a comparison image was available were signifi cant ( P , .001 ). Similarly, all of the bivariate associations with whether there was a change were signifi cant ( P , .001).
Comparison mammogram versus no comparison mammogram.-In the youngest age group (40-49 years), there were more women who had no comparison mammograms (46.3%) than there were women who had comparison mammograms (25.7%). mammographic fi ndings within the previous 12 months. Specifi city was defi ned as the proportion of patients without breast cancer who had negative mammographic fi ndings within the previous 12 months. Sensitivity, specifi city, and PPV 1 were calculated by using standard defi nitions ( 10 ) for mammographic interpretations with and without a comparison mammogram and then for the subgroup with comparison mammograms on which either change or no change was recorded.
We calculated unadjusted empirical estimates of cancer detection rates (per 1000 mammograms), sensitivity, specifi city, and PPV 1 separately for mammograms with comparison mammograms and for those without comparison mammograms. In addition, we calculated those measures separately for mammograms that showed a change from the comparison mammogram and those that showed no change from the comparison mammogram. These measures were also calculated by using breast density, which was dichotomized (entirely fat and scattered fi brodensities vs heterogeneously dense and extremely dense). Bivariate associations between availability of comparison mammograms and age, race, family history of breast cancer, use of hormone therapy, breast density, and history of breast surgery were also examined. Similar bivariate associations were examined between changes in the comparison image and the variables of interest. x 2 tests were used to determine if any of the bivariate associations were signifi cant. Logistic regression analysis was used to determine whether performance measures depend on the availability of comparison images after adjusting for other variables, including age (10-year age groups) and breast density. We assumed an independent working correlation matrix and used generalized estimating equations to account for data clustering. In addition, we accounted for the nonnested structure of clustering by fi tting three models with different clustering levels. The nonnested structureadjusted standard error of the parameter estimates is calculated by using the fi tted models ( 11 Table 2 ) . and 653 were diagnosed without a comparison mammogram. The cancer rate per 1000 mammograms was higher when there was no compari son image than when there was a comparison image (8.1 per 1000 mammograms vs 4.7 per 1000 mammograms). The cancer rate was lower when no change was reported than when a change was reported (1.8 per 1000 mammograms vs 25.4 per 1000 mammograms) ( Fig 1 ) .
Recall rate.-The overall recall rate for screening was 7.4% (85 926 of 1 157 980 mammograms). When cancer was present, the recall rate was 79.9% (4585 of 5738 cancers). When cancer was not present, the recall rate was 7.1% (81 348 per 1 152 242 mammograms). The fi rst set of models was run to determine whether sensitivity and specifi city depended on the presence of comparison mammograms. The Z statistics for the indicator of comparison mammograms for both sensitivity and specifi city were signifi cant ( P , .01). The next set of models was run to determine whether the sensitivity and specifi city depended on whether change was seen on the mammogram. The Z statistics for the indicator of change for both sensitivity and specifi city were signifi cant ( P , .01).
Discussion
Our results enable us to confi rm that having comparisons mammograms in a large community-based population leads comparison mammogram was present (7.1 per 1000 screening mammograms, 571 cancers on 80 186 mammograms) than when a comparison mammogram was present (3.7 per 1000 screening mammograms, 4014 cancers on 1 077 794 mammograms). When no change was noted, with a sensitivity of 44% and a low cancer rate, the cancer detection rate was 0.8 cancers per 1000 screening mammograms (731 of 940 056 mammograms). In the 12% of comparisons in which a change was noted, higher sensitivity and cancer rate led to a cancer detection rate of 24.5 cancers per 1000 mammograms (3248 of 132 123 mammograms) ( Fig 2 ) . Recommendation for biopsy.-We looked to see whether mammograms that revealed cancer in the presence of change and those that revealed cancer with no change led to different rates of recommendation for biopsy. With change, the biopsy recommendation rate was 6.9%; without change, the rate was 5.6%. When there was a change, 21.1% of cancers detected were ductal carcinoma in situ, and 79.0% were invasive carcinoma. When no change was noted, 19.3% of cancers detected were ductal carcinoma in situ, and 80.7% were invasive carcinoma ( Table 3 ) .
Logistic regression analysis results.-The unadjusted empirical estimates of (4585 of 5738 cancers). Sensitivity was higher (87.4%, 571 of 653 cancers) when there was no comparison mammogram than when there was a comparison mammogram (78.9%, 4014 of 5085 cancers). Sensitivity was lower (43.5%, 731 of 1680 cancers) when no change was reported than when change was reported (96.6%, 3248 of 3362 cancers) ( Fig 2 ) .
Overall unadjusted specifi city was 92.9% (1 070 901 Logistic regression analysis, which was used to control for multiple mammograms per patient and per facility and for age and breast density, did not alter the results.
Performance stratifi ed by breast density.-We calculated performance measures stratifi ed by breast density with a bivariate classifi cation of density. Comparison of (a) mammograms for which comparison mammograms were available with mammograms for which comparison mammograms were not available and (b) comparison of mammograms with a change with mammograms with no change yielded results similar to those presented. Across all measures, performance is better in fatty breasts than in dense breasts. Data are shown in Table  E1 (online).
Cancer detection rates.-The overall cancer detection rate was 4.0 per 1000 screening mammograms. The cancer detection rate was higher when no BREAST IMAGING: Change from Comparison Mammograms Yankaskas et al of cancer even though no change can be seen. With the low rate of cancer in the no-change group, this is a diffi cult task. The challenge is to improve discrimination, have less confi dence to ignore fi ndings when there is no change, and not immediately perform work-up when the mammogram is changed. In spite of the higher sensitivity with change, PPV 1 is still low at 7%. Burnside et al ( 2 ) found no difference in cancer detection rates when they used comparison mammograms, but they reported that the cancers were detected at an earlier stage and had better prognostic characteristics. We found that the cancers detected when we used comparison mammograms had a much higher proportion of ductal carcinoma in situ than when no comparison mammogram was present. The result of identifi cation tion rate of 24.5 per 1000, while the cancers for which no change was noted had a cancer detection rate of less than 1 per 1000. Thus, looking for change had the benefi t of enabling us to identify cancer, as few cancers were missed. The price paid for identifi cation of cancers was low specifi city and an associated falsepositive rate of 40%. If one evaluated the performance only on the basis of comparison, he or she would believe that sensitivity was lowered and specifi city was increased by comparison mammograms. This is because our results are weighted by the mammograms on which there was no change (88% of mammograms). When there was no change, sensitivity was less than 50% and the cancer detection rate was less than one per 1000 mammograms. Clearly, the challenge is to identify fi ndings that may be indicative to lower recall rates and higher overall specifi city ( 2-4,6,7 ) . We also found that comparison mammograms lead to lower sensitivity. For fi rst mammograms without comparison mammograms, it is known that sensitivity will be higher and specifi city will be lower because the women in whom these images were obtained are younger on average and a higher proportion of them have dense breasts ( 12 ) . Comparison mammograms are reviewed to look for change, and whether or not change is noted has a large effect on the recall rates and performance measures. Recall rates were 2.2 times higher when change was noted compared with when no change was noted. When change was noted, the radiologist was more likely to recommend further work-up. This occurred about 12% of the time and resulted in high sensitivity and low specifi city. When change was not noted, the fi nding was less likely to be recommended for work-up; this resulted in high specifi city and low sensitivity.
It is important to note that comparison mammograms were available in 93% of the study mammograms and that change was noted in 12.3% of these. As others have reported , use of comparison mammograms increases specifi city (4) (5) (6) (7) . This can be explained by the preponderance of comparisons in which there is no change that lead to decreased recall rates and lower falsepositive rates. However, the price for this is low sensitivity in the absence of change. The group of women in whom no comparison mammograms were available (6.9% of subjects) had a larger proportion of younger women than did the group of women in whom comparison mammograms were available; thus, the former group had a higher proportion of prevalent screening mammograms. As a result, they had more cancers, a higher sensitivity, and a higher cancer detection rate.
The 12% of mammograms on which change was noted had less effect on overall accuracy when we looked at mammography with comparison mammograms versus mammography with no comparison mammograms. The cancers for which change was noted had a detec- 
BREAST IMAGING: Change from Comparison Mammograms
Yankaskas et al of change is a high false-positive rate (no cancer) and potentially a substantial addition to over-diagnosis of breast cancer. This should be of concern to radiologists and calls for further research. In a population of 1 million women who undergo screening, a change will be seen on mammograms in approximately 123 000 women. Of these women, approximately 50 553 will undergo further examination. Cancer will be detected in approximately 3024 women, and approximately 47 519 women will undergo additional examinations when no cancer is present. Further examination will be performed in approximately 17 women for each cancer diagnosed. No change will be seen on approximately 877 000 mammograms. Approximately 17 693 women will undergo further examination, and approximately 885 cancers will be missed.
The strengths of this study are the population base and the number of screening mammograms. The results were obtained in actual community practice in a wide variety of settings and among a diverse population of women and radiologists. We excluded 0.5% of the mammograms because there was no information on whether the comparison mammogram was used. The cancer rate in this group of mammograms was close to that in the group of mammograms for which there were no comparison mammograms. It is our belief that when there was no information, the data entry clerks skipped this question rather than enter no mammogram . Regardless, the number of these cases is small and did not alter our results. In 12% of cases, information on whether there was a comparison mammogram was missing. Unfortunately, the comparison mammogram question asks whether there is a change from the previous mammogram. The responses are yes , no , no mammogram , and unknown . We did not ask what the change was. Another study will explore in more detail whether changes are new fi ndings, a change in density, or something else entirely, along with the actual fi ndings associated with accuracy and change. We did not use information on the time between the screening mammogram and the comparison mammogram. We will evaluate this in our continuing work.
We conclude that use of comparison mammograms when interpreting screening mammograms is helpful but should be viewed in terms of whether change is noted. When change is noted, the falsepositive rate is high. Attention needs to be paid to those recommended for further work-up to reduce the high rate of false-positive fi ndings without lowering the high sensitivity. The reverse is true when no change is noted; the specifi city is high but at the expense of low sensitivity, and a large proportion of cancers are missed in this subgroup. Future research should focus on improving sensitivity when there is no change and specifi city where there is a change. 
Yankaskas et al who underwent mammography at these facilities. Without these women, this work would not have been possible.
